[Interpretiation of guidelines for the diagnosis and management of aplastic anemia in China (2022)].
作者信息
Fu R, Wang T
机构信息
Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 Mar 14;44(3):188-192. doi: 10.3760/cma.j.issn.0253-2727.2023.03.003.
Abstract
摘要
相似文献
1
[Interpretiation of guidelines for the diagnosis and management of aplastic anemia in China (2022)].《中国再生障碍性贫血诊断与治疗指南（2022年版）》解读
Zhonghua Xue Ye Xue Za Zhi. 2023 Mar 14;44(3):188-192. doi: 10.3760/cma.j.issn.0253-2727.2023.03.003.
2
[Guidelines for the diagnosis and management of aplastic anemia in China (2022)].《中国再生障碍性贫血诊断与治疗指南（2022年版）》
Zhonghua Xue Ye Xue Za Zhi. 2022 Nov 14;43(11):881-888. doi: 10.3760/cma.j.issn.0253-2727.2022.11.001.
3
[Treatment of aplastic anemia in children].[儿童再生障碍性贫血的治疗]
Rinsho Ketsueki. 2014 Oct;55(10):1769-76.
4
Diagnosis and treatment of acquired aplastic anemia.获得性再生障碍性贫血的诊断与治疗
Hematol Oncol Clin North Am. 2009 Apr;23(2):159-70. doi: 10.1016/j.hoc.2009.01.005.
5
Acquired aplastic anemia in children.儿童获得性再生障碍性贫血。
Pediatr Clin North Am. 2013 Dec;60(6):1311-36. doi: 10.1016/j.pcl.2013.08.011. Epub 2013 Oct 16.
6
Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP).儿童获得性再生障碍性贫血的诊断与管理。意大利儿科血液肿瘤协会（AIEOP）骨髓衰竭研究组指南。
Blood Cells Mol Dis. 2015 Jun;55(1):40-7. doi: 10.1016/j.bcmd.2015.03.007. Epub 2015 Mar 31.
7
[Treatment of adult patients with aplastic anemia in Japan].[日本成年再生障碍性贫血患者的治疗]
Rinsho Ketsueki. 2005 Jun;46(6):389-93.
8
Severe fatigue: could it be aplastic anemia?严重疲劳：会是再生障碍性贫血吗？
Clin J Oncol Nurs. 2008 Aug;12(4):569-73. doi: 10.1188/08.CJON.569-573.
9
Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.儿童再生障碍性贫血免疫抑制治疗后复发：来自日本儿童再生障碍性贫血研究组的报告。
Haematologica. 2011 Jun;96(6):814-9. doi: 10.3324/haematol.2010.035600. Epub 2011 Mar 21.
10
Immunosuppressive therapy for transplant-ineligible aplastic anemia patients.针对不符合移植条件的再生障碍性贫血患者的免疫抑制治疗。
Expert Rev Hematol. 2015 Feb;8(1):89-99. doi: 10.1586/17474086.2015.978759.
引用本文的文献
1
A real-world pharmacovigilance analysis of hepatitis B vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database.一项使用美国疫苗不良事件报告系统（VAERS）数据库对乙型肝炎疫苗进行的真实世界药物警戒分析。
Sci Rep. 2025 Feb 19;15(1):6022. doi: 10.1038/s41598-025-90135-8.
本文引用的文献
1
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
2
Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag.预测重型再生障碍性贫血对基于兔抗胸腺细胞免疫球蛋白的免疫抑制疗法联合艾曲泊帕的反应。
Front Immunol. 2022 May 26;13:884312. doi: 10.3389/fimmu.2022.884312. eCollection 2022.
3
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.依鲁替尼联合免疫抑制治疗重型再生障碍性贫血。
N Engl J Med. 2022 Jan 6;386(1):11-23. doi: 10.1056/NEJMoa2109965.
4
Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.免疫抑制和艾曲波帕治疗重型再生障碍性贫血患者的长期结局：一项 2 期研究。
Blood. 2022 Jan 6;139(1):34-43. doi: 10.1182/blood.2021012130.
5
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag.预测重型再生障碍性贫血对免疫抑制联合艾曲泊帕的反应。
Haematologica. 2022 Jan 1;107(1):126-133. doi: 10.3324/haematol.2021.278413.
6
Young haploidentical donor versus fully matched elderly donor: An observational study on patients aged 50 years or older underwent hematopoietic progenitor cells transplantation.年轻单倍体供者与全相合老年供者：一项观察性研究，纳入年龄在 50 岁及以上接受造血祖细胞移植的患者。
Transfus Apher Sci. 2021 Apr;60(2):103032. doi: 10.1016/j.transci.2020.103032. Epub 2020 Dec 29.
7
Correlation of the Plasma Concentration of Eltrombopag With Efficacy in the Treatment of Refractory Aplastic Anemia: A Single-Centre Study in China.艾曲泊帕血浆浓度与难治性再生障碍性贫血治疗疗效的相关性：一项中国单中心研究。
Front Pharmacol. 2020 Nov 16;11:582625. doi: 10.3389/fphar.2020.582625. eCollection 2020.
8
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.再生障碍性贫血的异基因造血干细胞移植：当前的适应证及移植策略
Blood Rev. 2021 May;47:100772. doi: 10.1016/j.blre.2020.100772. Epub 2020 Oct 31.
9
Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study.罗米司亭治疗艾曲泊帕难治性再生障碍性贫血有效：一项回顾性研究的结果。
Int J Hematol. 2020 Dec;112(6):787-794. doi: 10.1007/s12185-020-02971-1. Epub 2020 Sep 2.
10
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years.对于年龄大于或小于 50 岁的 SAA 患者，基于阿仑单抗的造血细胞移植具有相似的疗效。
Blood Adv. 2019 Oct 22;3(20):3070-3079. doi: 10.1182/bloodadvances.2019000480.
Zotero 插件